EU drugs agency to review safety of contraceptives
LONDON Jan 28 (Reuters) - The European Medicines Agency said on Monday it would review the safety of third- and fourth-generation combined oral contraceptives to decide if there was a need to restrict their use.
The move follows a request by France, where authorities have already taken steps to reduce use of the drugs in favour of second-generation contraceptives.
(Reporting by Ben Hirschler)
- Divided, Scots prepare to vote on fate of the United Kingdom |
- IPhone emerges from 'bygone era', reviewers hail bigger handset
- Fed renews zero rate pledge, but hints at steeper rate hike path |
- Apple to unveil new iPads, operating system on Oct. 21: report
- Boeing, SpaceX win contracts to build 'space taxis' for NASA